Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation

Alzheimer's disease (AD) is a progressive, neurodegenerative disease characterized by extracellular β-amyloid (Aβ) plaques and intracellular neurofibrillary tangles in the brain. Aβ aggregation is closely associated with neurotoxicity, oxidative stress, and neuronal inflammation. The soluble Aβ oligomers are believed to be the most neurotoxic form among all forms of Aβ aggregates. We have previously reported a polyphenol compound rutin that could inhibit Aβ aggregation and cytotoxicity, attenuate oxidative stress, and decrease the production of nitric oxide and proinflammatory cytokines in vitro. In the current study, we investigated the effect of rutin on APPswe/PS1dE9 transgenic mice. Results demonstrated that orally administered rutin significantly attenuated memory deficits in AD transgenic mice, decreased oligomeric Aβ level, increased super oxide dismutase (SOD) activity and glutathione (GSH)/glutathione disulfide (GSSG) ratio, reduced GSSG and malondialdehyde (MDA) levels, downregulated microgliosis and astrocytosis, and decreased interleukin (IL)-1β and IL-6 levels in the brain. These results indicated that rutin is a promising agent for AD treatment because of its antioxidant, anti-inflammatory, and reducing Aβ oligomer activities.

[1]  D. Butterfield,et al.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. , 2001, Trends in molecular medicine.

[2]  T. Ishrat,et al.  Rutin protects the neural damage induced by transient focal ischemia in rats , 2009, Brain Research.

[3]  Xi Zhang,et al.  Conformation-dependent scFv antibodies specifically recognize the oligomers assembled from various amyloids and show colocalization of amyloid fibrils with oligomers in patients with amyloidoses. , 2011, Biochimica et biophysica acta.

[4]  Fabrizio Chiti,et al.  Prefibrillar Amyloid Protein Aggregates Share Common Features of Cytotoxicity* , 2004, Journal of Biological Chemistry.

[5]  W. Markesbery,et al.  Oxidative damage in mild cognitive impairment and early Alzheimer's disease , 2007, Journal of neuroscience research.

[6]  Yu-jiong Wang,et al.  Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines. , 2012, Neurotoxicology.

[7]  W. K. Cullen,et al.  Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo , 2005, Nature Medicine.

[8]  Claudio Soto,et al.  Unfolding the role of protein misfolding in neurodegenerative diseases , 2003, Nature Reviews Neuroscience.

[9]  Z. Song,et al.  Protective effects of bone morphogenetic protein 7 against amyloid-beta induced neurotoxicity in PC12 cells , 2011, Neuroscience.

[10]  Michael J Zaworotko,et al.  Cocrystals of quercetin with improved solubility and oral bioavailability. , 2011, Molecular pharmaceutics.

[11]  W. K. Cullen,et al.  Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. , 2005, Nature medicine.

[12]  P. S. M. Prince,et al.  Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes , 2006, Journal of biochemical and molecular toxicology.

[13]  C. Glabe.  Conformation-dependent antibodies target diseases of protein misfolding. , 2004, Trends in biochemical sciences.

[14]  R. Khan,et al.  Protective effects of rutin against potassium bromate induced nephrotoxicity in rats , 2012, BMC Complementary and Alternative Medicine.

[15]  C. Glabe,et al.  Structural Classification of Toxic Amyloid Oligomers* , 2008, Journal of Biological Chemistry.

[16]  C. Glabe.  Common mechanisms of amyloid oligomer pathogenesis in degenerative disease , 2006, Neurobiology of Aging.

[17]  Manjeet Singh,et al.  Neuroprotective effect of antioxidants on ischaemia and reperfusion-induced cerebral injury. , 2003, Pharmacological research.

[18]  B. Penke,et al.  Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology. , 2011, Brain : a journal of neurology.

[19]  R. Kayed,et al.  Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases* , 2004, Journal of Biological Chemistry.

[20]  Takao Kaneko,et al.  SOD1 (Copper/Zinc Superoxide Dismutase) Deficiency Drives Amyloid β Protein Oligomerization and Memory Loss in Mouse Model of Alzheimer Disease* , 2011, The Journal of Biological Chemistry.

[21]  D. Sept,et al.  Multivariate Analyses of Amyloid-Beta Oligomer Populations Indicate a Connection between Pore Formation and Cytotoxicity , 2012, PloS one.

[22]  C. Winterbourn,et al.  Protein carbonyl measurement by enzyme-linked immunosorbent assay. , 1999, Methods in enzymology.

[23]  S. Sultana,et al.  Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFκB, TNF-α and caspase-3 expression in wistar rats. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[24]  R. Wetzel,et al.  Conformational Abs recognizing a generic amyloid fibril epitope , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Geldenhuys,et al.  Oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agents , 2010, Expert review of neurotherapeutics.

[26]  Y. Kitamura,et al.  Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. , 2007, Journal of pharmacological sciences.

[27]  M. Laakso,et al.  Astrogliosis and the ApoE Genotype , 1999, Dementia and Geriatric Cognitive Disorders.

[28]  J. Morillas-Ruiz,et al.  A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines , 2012, TheScientificWorldJournal.

[29]  Y. Kuroda,et al.  Rutin Supplementation in the Diet has Protective Effects Against Toxicant-Induced Hippocampal Injury by Suppression of Microglial Activation and Pro-Inflammatory Cytokines , 2009, Cellular and Molecular Neurobiology.

[30]  Ian Parker,et al.  Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.

[31]  H. Javed,et al.  Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type , 2012, Neuroscience.

[32]  J. Hirrlinger,et al.  Glutathione metabolism in brain , 2000 .

[33]  C. Vorhees,et al.  Morris water maze: procedures for assessing spatial and related forms of learning and memory , 2006, Nature Protocols.

[34]  J. Crapo,et al.  Biology of disease: free radicals and tissue injury. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[35]  A. Giese,et al.  Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols. , 2013, Biochimica et biophysica acta.

[36]  H. Lee,et al.  Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease , 2012, Brain Research Bulletin.

[37]  P. Davies,et al.  Resveratrol mitigates lipopolysaccharide‐ and Aβ‐mediated microglial inflammation by inhibiting the TLR4/NF‐κB/STAT signaling cascade , 2012, Journal of neurochemistry.

[38]  J. Maag,et al.  Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical. , 2012, Food & function.

[39]  G. Ricevuti,et al.  Mitochondrial Alterations, Oxidative Stress and Neuroinflammation in Alzheimer's Disease , 2012, International journal of immunopathology and pharmacology.

[40]  Y. Fukuuchi,et al.  Microglia-specific localisation of a novel calcium binding protein, Iba1. , 1998, Brain research. Molecular brain research.

[41]  J. Hirrlinger,et al.  Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. , 2000, European journal of biochemistry.

[42]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[43]  Xiongwei Zhu,et al.  Oxidative stress: the old enemy in Alzheimer's disease pathophysiology. , 2005, Current Alzheimer research.

[44]  P. Bickford,et al.  Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease. , 2010, International journal of pharmaceutics.

[45]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[46]  F. Heppner,et al.  Microglia actions in Alzheimer’s disease , 2013, Acta Neuropathologica.